Pertinacious prescription of practice paradigms: The ethical burden of coercive clinical guidelines William M. Landau Invited Commentary 12 September 2007 Pages: 355 - 358
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease Karen Marder Clinical Trials Report 12 September 2007 Pages: 363 - 365
Diet and Alzheimer’s disease José A. LuchsingerJames M. NobleNikolaos Scarmeas OriginalPaper 12 September 2007 Pages: 366 - 372
Type 2 diabetes and risk of cognitive impairment and dementia Rachel A. Whitmer OriginalPaper 12 September 2007 Pages: 373 - 380
Laboratory biomarkers in Alzheimer’s disease Joshua R. SteinermanLawrence S. Honig OriginalPaper 12 September 2007 Pages: 381 - 387
An update on primary progressive aphasia Emily RogalskiMarsel Mesulam OriginalPaper 12 September 2007 Pages: 388 - 392
Memantine/gabapentin for the treatment of congenital nystagmus James Corbett Clinical Trials Report 12 September 2007 Pages: 395 - 396
Horner’s syndrome, Pseudo-Horner’s syndrome, and simple anisocoria Timothy J. Martin OriginalPaper 12 September 2007 Pages: 397 - 406
Disorders of saccades Matthew J. ThurtellRobert L. TomsakR. John Leigh OriginalPaper 12 September 2007 Pages: 407 - 416
The dilated pupil: An update Jeremy J. MoellerCharles E. Maxner OriginalPaper 12 September 2007 Pages: 417 - 422
Common neurodegenerative diseases: Dissection by genome-wide association Vincenzo Bonifati OriginalPaper Open access 12 September 2007 Pages: 425 - 427
Advances in Lafora progressive myoclonus epilepsy Antonio V. Delgado-Escueta OriginalPaper 12 September 2007 Pages: 428 - 433
The genetics of frontotemporal lobar degeneration Rosa RademakersMike Hutton OriginalPaper 12 September 2007 Pages: 434 - 442
Autophagy and neurodegeneration Annamaria VentrutiAna Maria Cuervo OriginalPaper 12 September 2007 Pages: 443 - 451